Invest in Innovation
McGinley Orthopedics is pushing the stagnating sector of orthopedic technology forward with groundbreaking patents and innovation.
The PRoblem
Outdated Tools Cause Over-Drilling & Improperly Installed Screws
The outcomes are as scary as they look. There are many different complications that can arise when correcting distal radius fractures. The most frequent complication is a malunion or misalignment. The effects on patients can range from pain and long-term discomfort to replacement surgery.
53%
of surgeons self-reported errors in the last 6 months
1 In 5
of surgeons self-reported errors in the last 6 months
53%
of surgeons self-reported errors in the last 6 months
Patent Growth
McGinley Orthopedics has a proven record of success in the operating room. We’re currently partnered with hospitals and universities across the country. Our technologies have been used in over 1,000 successful surgeries.
115
Issued Patents
14
Pending Patents
Our Mission
Engineer An Improved Standard of Care
Play Video
There has been very little innovation in surgical drill and distal radius plating systems. Surgeons have to rely on outdated and unsophisticated tools and implant technologies.
At McGinley Orthopedics, we aim to utilize innovative engineering to improve patient outcomes while reducing costs.
our solutions
The Future of Orthopedics
IntelliSense Drill Technology®
$2.7B Market
The ONLY drill designed with patient safety in mind. Unprecedented safety features like edge-detection and auto-stop help to keep patients safe and prevent complications.
Lever Action Plate System®
$4.3B Market
Infinitely adjustable to improve alignment and patient outcomes.
Custom Accessories
$650M Market
Our vertical integration allows us to spin up custom solutions – fast.
“
Testimonial
Redefining the Technique of Depth Sensing
“For over 20 years, McGinley Orthopedics and it’s affiliates have built a robust patent portfolio. The patents in this portfolio provide strong protection for innovative aspects of the McGinley Orthopedics product line in the U.S. and key foreign jurisdictions. The existing patent portfolio coupled with ongoing efforts to secure patents for key technologies continue to differentiate McGinley Orthopedics as a technological leader in the field.“
Jon Deppe | Shareholder at Holzer Patel Drennan
our solutions
Invest in 100% In-House Engineering & Manufacturing
Sometimes when you want something done right, you have to do it yourself. We design and construct everything we offer – 100% in-house
6
Products in Pipeline
129
issued & Pending Patents
5
Products On Market
featured on
IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. REGULATION A OFFERINGS ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.
McGinley Orthopaedic Innovations is offering securities through the use of an Offering Statement that the Securities and Exchange Commission (‘SEC”) has qualified under Tier II of Regulation A. While the SEC staff reviews certain forms and filings for compliance with disclosure obligations, the SEC does not evaluate the merits of any offering, nor does it determine if any securities offered are “good” investments.
Rialto Markets LLC (“Rialto”) is registered with the Securities and Exchange Commission (“SEC”) as a broker-dealer, member of Financial Industry Regulatory Authority, Inc. (“FINRA”) and Securities Investor Protection Corporation (“SIPC”) and is the broker-dealer of record on this issuer direct offering.
This profile may contain forward-looking statements and information relating to, among other things, the company, its business plan and strategy, and its markets or industry. These statements reflect management’s current views regarding future events based on available information and are subject to risks and uncertainties that could cause the company’s actual results to differ materially. Investors are cautioned not to place undue reliance on these forward-looking statements as they are meant for illustrative purposes, and they do not represent guarantees of future results, levels of activity, performance, or achievements, all of which cannot be made. Moreover, although management believes that the expectations reflected in the forward-looking statements are reasonable, neither McGinley Orthopaedic Innovations nor anyone acting on its behalf can give any assurance that such expectations will prove to have been correct nor do they have a duty to update any such statements to conform them to actual results.
By accessing this site and any pages on this site, you agree to be bound by our Terms of Use and Privacy Policy, as may be amended from time to time without notice or liability.